Loading…

Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes

The role of ferroptosis, a new form of cell death, in bladder cancer (BC) has not been sufficiently studied. This study aimed to establish a prognostic prediction model for BC patients based on the expression profile of ferroptosis-related genes (FRG). The expression profiles of BC samples with clin...

Full description

Saved in:
Bibliographic Details
Published in:Aging (Albany, NY.) NY.), 2022-11, Vol.14 (22), p.9037-9055
Main Authors: Li, Lianjun, Zhao, Leizuo, Li, Bin, Wang, Tengteng, Kang, Weiting, Cui, Zilian, Liu, Dongjian, Gu, Da
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 9055
container_issue 22
container_start_page 9037
container_title Aging (Albany, NY.)
container_volume 14
creator Li, Lianjun
Zhao, Leizuo
Li, Bin
Wang, Tengteng
Kang, Weiting
Cui, Zilian
Liu, Dongjian
Gu, Da
description The role of ferroptosis, a new form of cell death, in bladder cancer (BC) has not been sufficiently studied. This study aimed to establish a prognostic prediction model for BC patients based on the expression profile of ferroptosis-related genes (FRG). The expression profiles of BC samples with clinical information were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). A total of 80 differentially expressed genes (DEGs) related to FRG were identified among which 37 DEGs were found to have a prognostic value. Eleven genetic markers including SLC2A12, CDO1, JDP2, MAFG, CAPG, RRM2, SLC2A3, SLC3A2, VDAC2, GCH1, and ANGPTL7 were identified through the LASSO regression analysis. The ROC curve analysis showed that the AUC was 0.702, 0.664, and 0.655 for the 1-year, 3-year, and 5-year survival outcomes, respectively. The prediction performance was verified in the TCGA-testing set and external set GSE13507. Multivariate Cox proportional hazards analysis showed that the risk score was an independent prognostic predictor. Moreover, we found differences in gene mutation, gene expression, and immune cell infiltration between the high and low-risk groups of BC patients. Finally, a nomogram was constructed by integrating clinical features and FRG signatures to predict the survival outcomes of BC patients. In addition, the differential expression of FRG mRNA and protein was verified through PCR and HPA online site. The characteristics of 11 FRG genes were examined and a prognostic nomogram for predicting the overall survival of BC was established.
doi_str_mv 10.18632/aging.204385
format article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9740359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>36399105</sourcerecordid><originalsourceid>FETCH-LOGICAL-p163t-2a94b32cddca05e0b15f11c54788e0cef04444d1540ea900fa5b81cd47870c4c3</originalsourceid><addsrcrecordid>eNpVkE1LxDAQhoMg7rp69Cr5A9WkSbrtRZD1Exa86LlMk2k30iYl6RYEf7wRP9A5zAvzzjzDDCFnnF3wshD5JXTWdRc5k6JUB2TJK6kyqcpqQY5jfGWsUEoWR2QhClFVnKkleb_BGXs_DugmCs7QGXprYLLeUd9SoM4nnw7epNz6QMeAxuop7aHTDmnch9mmmc_mpgdjMFANTidpIKKhidNiCH6cfLQxC9jDlModOown5LCFPuLpt67Iy93t8-Yh2z7dP26ut9nICzFlOVSyEbk2RgNTyBquWs61kuuyRKaxZTKF4UoyhIqxFlRTcm2Sv2ZaarEiV1_ccd8MaHS6NUBfj8EOEN5qD7b-7zi7qzs_19VaMqGqBDj_C_id_Pmj-ADWeHeG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes</title><source>PMC (PubMed Central)</source><creator>Li, Lianjun ; Zhao, Leizuo ; Li, Bin ; Wang, Tengteng ; Kang, Weiting ; Cui, Zilian ; Liu, Dongjian ; Gu, Da</creator><creatorcontrib>Li, Lianjun ; Zhao, Leizuo ; Li, Bin ; Wang, Tengteng ; Kang, Weiting ; Cui, Zilian ; Liu, Dongjian ; Gu, Da</creatorcontrib><description>The role of ferroptosis, a new form of cell death, in bladder cancer (BC) has not been sufficiently studied. This study aimed to establish a prognostic prediction model for BC patients based on the expression profile of ferroptosis-related genes (FRG). The expression profiles of BC samples with clinical information were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). A total of 80 differentially expressed genes (DEGs) related to FRG were identified among which 37 DEGs were found to have a prognostic value. Eleven genetic markers including SLC2A12, CDO1, JDP2, MAFG, CAPG, RRM2, SLC2A3, SLC3A2, VDAC2, GCH1, and ANGPTL7 were identified through the LASSO regression analysis. The ROC curve analysis showed that the AUC was 0.702, 0.664, and 0.655 for the 1-year, 3-year, and 5-year survival outcomes, respectively. The prediction performance was verified in the TCGA-testing set and external set GSE13507. Multivariate Cox proportional hazards analysis showed that the risk score was an independent prognostic predictor. Moreover, we found differences in gene mutation, gene expression, and immune cell infiltration between the high and low-risk groups of BC patients. Finally, a nomogram was constructed by integrating clinical features and FRG signatures to predict the survival outcomes of BC patients. In addition, the differential expression of FRG mRNA and protein was verified through PCR and HPA online site. The characteristics of 11 FRG genes were examined and a prognostic nomogram for predicting the overall survival of BC was established.</description><identifier>EISSN: 1945-4589</identifier><identifier>DOI: 10.18632/aging.204385</identifier><identifier>PMID: 36399105</identifier><language>eng</language><publisher>United States: Impact Journals</publisher><subject>Angiopoietin-like Proteins ; Cell Death ; Ferroptosis - genetics ; Humans ; Nomograms ; Research Paper ; Risk Factors ; Urinary Bladder Neoplasms - genetics</subject><ispartof>Aging (Albany, NY.), 2022-11, Vol.14 (22), p.9037-9055</ispartof><rights>Copyright: © 2022 Li et al.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740359/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740359/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36399105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Lianjun</creatorcontrib><creatorcontrib>Zhao, Leizuo</creatorcontrib><creatorcontrib>Li, Bin</creatorcontrib><creatorcontrib>Wang, Tengteng</creatorcontrib><creatorcontrib>Kang, Weiting</creatorcontrib><creatorcontrib>Cui, Zilian</creatorcontrib><creatorcontrib>Liu, Dongjian</creatorcontrib><creatorcontrib>Gu, Da</creatorcontrib><title>Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes</title><title>Aging (Albany, NY.)</title><addtitle>Aging (Albany NY)</addtitle><description>The role of ferroptosis, a new form of cell death, in bladder cancer (BC) has not been sufficiently studied. This study aimed to establish a prognostic prediction model for BC patients based on the expression profile of ferroptosis-related genes (FRG). The expression profiles of BC samples with clinical information were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). A total of 80 differentially expressed genes (DEGs) related to FRG were identified among which 37 DEGs were found to have a prognostic value. Eleven genetic markers including SLC2A12, CDO1, JDP2, MAFG, CAPG, RRM2, SLC2A3, SLC3A2, VDAC2, GCH1, and ANGPTL7 were identified through the LASSO regression analysis. The ROC curve analysis showed that the AUC was 0.702, 0.664, and 0.655 for the 1-year, 3-year, and 5-year survival outcomes, respectively. The prediction performance was verified in the TCGA-testing set and external set GSE13507. Multivariate Cox proportional hazards analysis showed that the risk score was an independent prognostic predictor. Moreover, we found differences in gene mutation, gene expression, and immune cell infiltration between the high and low-risk groups of BC patients. Finally, a nomogram was constructed by integrating clinical features and FRG signatures to predict the survival outcomes of BC patients. In addition, the differential expression of FRG mRNA and protein was verified through PCR and HPA online site. The characteristics of 11 FRG genes were examined and a prognostic nomogram for predicting the overall survival of BC was established.</description><subject>Angiopoietin-like Proteins</subject><subject>Cell Death</subject><subject>Ferroptosis - genetics</subject><subject>Humans</subject><subject>Nomograms</subject><subject>Research Paper</subject><subject>Risk Factors</subject><subject>Urinary Bladder Neoplasms - genetics</subject><issn>1945-4589</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LxDAQhoMg7rp69Cr5A9WkSbrtRZD1Exa86LlMk2k30iYl6RYEf7wRP9A5zAvzzjzDDCFnnF3wshD5JXTWdRc5k6JUB2TJK6kyqcpqQY5jfGWsUEoWR2QhClFVnKkleb_BGXs_DugmCs7QGXprYLLeUd9SoM4nnw7epNz6QMeAxuop7aHTDmnch9mmmc_mpgdjMFANTidpIKKhidNiCH6cfLQxC9jDlModOown5LCFPuLpt67Iy93t8-Yh2z7dP26ut9nICzFlOVSyEbk2RgNTyBquWs61kuuyRKaxZTKF4UoyhIqxFlRTcm2Sv2ZaarEiV1_ccd8MaHS6NUBfj8EOEN5qD7b-7zi7qzs_19VaMqGqBDj_C_id_Pmj-ADWeHeG</recordid><startdate>20221117</startdate><enddate>20221117</enddate><creator>Li, Lianjun</creator><creator>Zhao, Leizuo</creator><creator>Li, Bin</creator><creator>Wang, Tengteng</creator><creator>Kang, Weiting</creator><creator>Cui, Zilian</creator><creator>Liu, Dongjian</creator><creator>Gu, Da</creator><general>Impact Journals</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>5PM</scope></search><sort><creationdate>20221117</creationdate><title>Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes</title><author>Li, Lianjun ; Zhao, Leizuo ; Li, Bin ; Wang, Tengteng ; Kang, Weiting ; Cui, Zilian ; Liu, Dongjian ; Gu, Da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p163t-2a94b32cddca05e0b15f11c54788e0cef04444d1540ea900fa5b81cd47870c4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Angiopoietin-like Proteins</topic><topic>Cell Death</topic><topic>Ferroptosis - genetics</topic><topic>Humans</topic><topic>Nomograms</topic><topic>Research Paper</topic><topic>Risk Factors</topic><topic>Urinary Bladder Neoplasms - genetics</topic><toplevel>online_resources</toplevel><creatorcontrib>Li, Lianjun</creatorcontrib><creatorcontrib>Zhao, Leizuo</creatorcontrib><creatorcontrib>Li, Bin</creatorcontrib><creatorcontrib>Wang, Tengteng</creatorcontrib><creatorcontrib>Kang, Weiting</creatorcontrib><creatorcontrib>Cui, Zilian</creatorcontrib><creatorcontrib>Liu, Dongjian</creatorcontrib><creatorcontrib>Gu, Da</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Aging (Albany, NY.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Lianjun</au><au>Zhao, Leizuo</au><au>Li, Bin</au><au>Wang, Tengteng</au><au>Kang, Weiting</au><au>Cui, Zilian</au><au>Liu, Dongjian</au><au>Gu, Da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes</atitle><jtitle>Aging (Albany, NY.)</jtitle><addtitle>Aging (Albany NY)</addtitle><date>2022-11-17</date><risdate>2022</risdate><volume>14</volume><issue>22</issue><spage>9037</spage><epage>9055</epage><pages>9037-9055</pages><eissn>1945-4589</eissn><abstract>The role of ferroptosis, a new form of cell death, in bladder cancer (BC) has not been sufficiently studied. This study aimed to establish a prognostic prediction model for BC patients based on the expression profile of ferroptosis-related genes (FRG). The expression profiles of BC samples with clinical information were obtained from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO). A total of 80 differentially expressed genes (DEGs) related to FRG were identified among which 37 DEGs were found to have a prognostic value. Eleven genetic markers including SLC2A12, CDO1, JDP2, MAFG, CAPG, RRM2, SLC2A3, SLC3A2, VDAC2, GCH1, and ANGPTL7 were identified through the LASSO regression analysis. The ROC curve analysis showed that the AUC was 0.702, 0.664, and 0.655 for the 1-year, 3-year, and 5-year survival outcomes, respectively. The prediction performance was verified in the TCGA-testing set and external set GSE13507. Multivariate Cox proportional hazards analysis showed that the risk score was an independent prognostic predictor. Moreover, we found differences in gene mutation, gene expression, and immune cell infiltration between the high and low-risk groups of BC patients. Finally, a nomogram was constructed by integrating clinical features and FRG signatures to predict the survival outcomes of BC patients. In addition, the differential expression of FRG mRNA and protein was verified through PCR and HPA online site. The characteristics of 11 FRG genes were examined and a prognostic nomogram for predicting the overall survival of BC was established.</abstract><cop>United States</cop><pub>Impact Journals</pub><pmid>36399105</pmid><doi>10.18632/aging.204385</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1945-4589
ispartof Aging (Albany, NY.), 2022-11, Vol.14 (22), p.9037-9055
issn 1945-4589
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9740359
source PMC (PubMed Central)
subjects Angiopoietin-like Proteins
Cell Death
Ferroptosis - genetics
Humans
Nomograms
Research Paper
Risk Factors
Urinary Bladder Neoplasms - genetics
title Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A06%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20novel%20model%20for%20predicting%20the%20survival%20of%20bladder%20cancer%20based%20on%20ferroptosis-related%20genes&rft.jtitle=Aging%20(Albany,%20NY.)&rft.au=Li,%20Lianjun&rft.date=2022-11-17&rft.volume=14&rft.issue=22&rft.spage=9037&rft.epage=9055&rft.pages=9037-9055&rft.eissn=1945-4589&rft_id=info:doi/10.18632/aging.204385&rft_dat=%3Cpubmed%3E36399105%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p163t-2a94b32cddca05e0b15f11c54788e0cef04444d1540ea900fa5b81cd47870c4c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/36399105&rfr_iscdi=true